NDC product
Adrenapar
NDC 44911-0715 · Energique, Inc.
Key facts
| Product NDC | 44911-0715 |
|---|---|
| Proprietary name | Adrenapar |
| Nonproprietary name | Aralia Quinquefolia, Avena Sativa, Glandula Suprarenalis Suis, Hypothalamus Suis, Arsenicum Iodatum, Calcarea Carbonica, Ignatia Amara, Lycopodium Clavatum, Natrum Muriaticum, Nux Vomica, Phosphoricum Acidum, Phosphorus and 1 more |
| Substances | AMERICAN GINSENG, AVENA SATIVA FLOWERING TOP, SUS SCROFA ADRENAL GLAND, SUS SCROFA HYPOTHALAMUS, ARSENIC TRIIODIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, STRYCHNOS IGNATII SEED, LYCOPODIUM CLAVATUM SPORE, SODIUM CHLORIDE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORIC ACID, PHOSPHORUS and 1 more |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Energique, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED HOMEOPATHIC |
| Pharmacologic classes | Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS] and 1 more |
| Marketing start | Jul 29, 2024 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: